BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/14/2019 11:25:18 AM | Browse: 740 | Download: 1500
 |
Received |
|
2019-02-20 05:40 |
|
Peer-Review Started |
|
2019-02-20 07:00 |
|
To Make the First Decision |
|
2019-04-30 10:08 |
|
Return for Revision |
|
2019-05-05 01:13 |
|
Revised |
|
2019-05-30 15:51 |
|
Second Decision |
|
2019-06-05 10:31 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-06-08 15:09 |
|
Articles in Press |
|
2019-06-08 15:09 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-07-13 11:42 |
|
Publish the Manuscript Online |
|
2019-07-14 11:25 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Infectious Diseases |
| Manuscript Type |
Opinion Review |
| Article Title |
Fluoroquinolones for the treatment of latent Mycobacterium tuberculosis infection in liver transplantation
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jose Tiago Silva, Rafael San-Juan, Mario Fernandez-Ruiz and Jose Maria Aguado |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| “Plan Nacional de I+D+I” |
|
| Instituto de Salud Carlos III (Fondo de Investigaciones Sanitarias [FIS] PI14/00174), Subdirección General de Redes y Centros de Investigación Cooperativa, Spanish Ministry of Science, Innovation and Universities, Spanish Network for Research in Infectious Diseases (REIPI RD16/0016) |
|
|
| Corresponding Author |
Jose Tiago Silva, MD, PhD, Attending Doctor, Postdoc, Unit of Infectious Diseases, Hospital Universitario “12 de Octubre”, Instituto de Investigación Hospital “12 de Octubre” (imas12), School of Medicine, Universidad Complutense, 2ª planta, bloque D. Avda. de Córdoba, s/n, Madrid 28041, Spain. j.tiago.silva@hotmail.com |
| Key Words |
Fluoroquinolones; Mycobacterium tuberculosis; Latent tuberculosis infection; Liver transplantation; Drug-induced liver graft injury |
| Core Tip |
Active tuberculosis after solid organ transplantation, particularly after liver transplantation, has a dismal outcome. This review focuses on the burden of active tuberculosis after liver transplantation and summarizes the most recent data concerning the use of isoniazid for the treatment of latent tuberculosis infection in liver transplant recipients and candidates. In addition, we review the most relevant clinical experience in the use of fluoroquinolones as an alternative approach with a favorable safety profile for the treatment of latent tuberculosis infection in the liver transplant setting. |
| Publish Date |
2019-07-14 11:25 |
| Citation |
Silva JT, San-Juan R, Fernández-Ruiz M, Aguado JM. Fluoroquinolones for the treatment of latent Mycobacterium tuberculosis infection in liver transplantation. World J Gastroenterol 2019; 25(26): 3291-3298 |
| URL |
https://www.wjgnet.com/1007-9327/full/v25/i26/3291.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v25.i26.3291 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
